Lyell Immunopharma, Inc. (LYEL) Ownership

$9.69

$0.26 (2.76%)
Last update: 01:00 PM EST
Day's range
$9.37
Day's range
$9.81

Lyell Immunopharma, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
MWG MANAGEMENT LTD. 05/13/2025 20.16 M $10.85 M   0.00% 6.83%
FORESITE CAPITAL MANAGEMENT IV, LLC 05/15/2025 16.01 M $8.61 M   92.29% 5.42%
ORLAND PROPERTIES LTD 05/13/2025 15.09 M $8.15 M   0.00% 5.11%
BLACKROCK, INC. 05/02/2025 12.72 M $6.84 M   -4.10% 4.31%
DECHENG CAPITAL LLC 05/08/2025 11.91 M $6.41 M   0.00% 4.04%
VANGUARD GROUP INC 05/09/2025 9.74 M $5.24 M   -0.29% 3.30%
FORESITE CAPITAL MANAGEMENT V, LLC 05/15/2025 8.13 M $4.38 M   0.00% 2.76%
VENBIO PARTNERS LLC 05/15/2025 7.10 M $3.82 M   0.00% 2.41%
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 6.48 M $3.49 M   -6.25% 2.20%
ALPHABET INC. 05/02/2025 5.87 M $3.17 M   0.00% 1.99%
CITADEL ADVISORS LLC 05/15/2025 4.51 M $2.35 M   20.03% 1.53%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 4.40 M $2.37 M   6.33% 1.49%
STATE STREET CORP 05/15/2025 3.70 M $1.99 M   -1.23% 1.25%
SC CHINA HOLDING LTD 05/13/2025 3.05 M $1.46 M   0.00% 1.03%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 1.77 M $951.45 K   9.70% 0.60%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 1.60 M $863.32 K   -2.50% 0.54%
NORTHERN TRUST CORP 05/13/2025 1.30 M $696.75 K   -1.16% 0.44%
TD ASSET MANAGEMENT INC 05/07/2025 1.00 M $540.50 K   0.00% 0.34%
IKARIAN CAPITAL, LLC 05/15/2025 876.04 K $471.31 K   -31.35% 0.30%
MORGAN STANLEY 05/15/2025 866.40 K $466.13 K   -28.65% 0.29%
JOHNSON & JOHNSON 05/07/2025 823.32 K $442.95 K   0.00% 0.28%
ACADIAN ASSET MANAGEMENT LLC 05/21/2025 660.90 K $354.00 K   204.16% 0.22%
05/12/2025 641.17 K $344.95 K   100.00% 0.22%
CANADA PENSION PLAN INVESTMENT BOARD 05/15/2025 588.24 K $316.47 K   0.00% 0.20%
JACOBS LEVY EQUITY MANAGEMENT, INC 05/15/2025 558.98 K $300.73 K   -59.65% 0.19%
BANK OF NEW YORK MELLON CORP 04/29/2025 525.78 K $282.87 K   0.00% 0.18%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 05/15/2025 513.83 K $276.44 K   -6.89% 0.17%
CLARIUS GROUP, LLC 04/18/2025 399.17 K $214.75 K   0.00% 0.14%
TWO SIGMA ADVISERS, LP 05/15/2025 391.20 K $210.47 K   27.68% 0.13%
TWO SIGMA INVESTMENTS, LP 05/15/2025 387.68 K $208.57 K   89.57% 0.13%
INVESCO LTD. 05/12/2025 378.88 K $203.84 K   -6.96% 0.13%
GOLDMAN SACHS GROUP INC 06/27/2025 358.59 K $192.92 K   -42.84% 0.12%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 05/15/2025 295.65 K $159.06 K   -4.18% 0.10%
EXCHANGE TRADED CONCEPTS, LLC 04/17/2025 246.35 K $132.54 K   82.41% 0.08%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2025 244.71 K $131.66 K   -39.76% 0.08%
RHUMBLINE ADVISERS 05/29/2025 235.69 K $126.79 K   -16.16% 0.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 234.94 K $126.40 K   27.59% 0.08%
ALLIANCEBERNSTEIN L.P. 05/15/2025 220.79 K $118.79 K   0.00% 0.07%
SQUAREPOINT OPS LLC 05/15/2025 198.32 K $106.70 K   100.00% 0.07%
JPMORGAN CHASE & CO 05/12/2025 194.65 K $104.72 K   -55.07% 0.07%
BARCLAYS PLC 05/15/2025 183.47 K $99.00 K   -28.99% 0.06%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 174.28 K $93.76 K   773.49% 0.06%
BNP PARIBAS ARBITRAGE, SNC 05/14/2025 166.25 K $89.44 K   -34.46% 0.06%
BBR PARTNERS, LLC 05/14/2025 164.04 K $88.25 K   0.00% 0.06%
RAYMOND JAMES FINANCIAL INC 05/13/2025 158.00 K $85.00 K   100.00% 0.05%
INTECH INVESTMENT MANAGEMENT LLC 05/20/2025 124.70 K $67.09 K   80.14% 0.04%
TUDOR INVESTMENT CORP ET AL 05/15/2025 124.32 K $66.88 K   0.00% 0.04%
CITIGROUP INC 05/12/2025 117.91 K $63.43 K   -10.59% 0.04%
UBS GROUP AG 05/13/2025 110.40 K $59.40 K   -87.23% 0.04%
WELLS FARGO & COMPANY/MN 05/13/2025 96.45 K $51.89 K   2.26% 0.03%

Lyell Immunopharma, Inc. institutional Ownership - FAQ's

During the previous two years, 126 institutional investors and hedge funds held shares of Lyell Immunopharma, Inc.. The most heavily invested institutionals were:

MWG Management Ltd.: 20.16 M

Foresite Capital Management IV, LLC: 16.01 M

Orland Properties Ltd: 15.09 M

BlackRock, Inc.: 12.72 M

Decheng Capital LLC: 11.91 M

VANGUARD GROUP INC: 9.74 M

49.92% of Lyell Immunopharma, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 184.86 M shares in the last 24 months. This purchase volume represents approximately $1.79 B in transactions.